Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Status
Approved
Full Title
ORPHENGESIC FORTE TABLETS (Orphenadrine Citrate, Aspirin and Caffeine tablets 50 mg/ 770mg/ 60 mg USP)
United States
Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.
